DXCM
$85.99
Revenue | $1113.5Mn |
Net Profits | $151.7Mn |
Net Profit Margins | 13.62% |
Dexcom, Inc.’s revenue jumped 7.64% since last year same period to $1113.5Mn in the Q4 2024. On a quarterly growth basis, Dexcom, Inc. has generated 12% jump in its revenue since last 3-months.
Dexcom, Inc.’s net profit fell -40.81% since last year same period to $151.7Mn in the Q4 2024. On a quarterly growth basis, Dexcom, Inc. has generated 12.7% jump in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin fell -45.01% since last year same period to 13.62% in the Q4 2024. On a quarterly growth basis, Dexcom, Inc. has generated 0.63% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.52 |
EPS Estimate Current Year | 0.52 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.52 - a 18.18% jump from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.52.
Earning Per Share (EPS) | 0.45 |
Dexcom, Inc.’s earning per share (EPS) fell -10% since last year same period to 0.45 in the Q4 2024. This indicates that the Dexcom, Inc. has generated -10% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-07-25 | 0.39 | 0.43 | 10.26% |
2024-10-24 | 0.44 | 0.45 | 2.27% |
2024-12-31 | 0.52 | 0.45 | -13.46% |
2024-04-25 | 0.27 | 0.32 | 18.52% |